NEWS

Enzychem Lifesciences Corporation’s presentation at AASLD The Liver Meeting® 2019 in Boston.

  • 2019.11.13
  • PUBLICATION

SMC announced that Enzychem Lifesciences Corporation (Korea) presented results of a study using STAM™ model at poster presentation at AASLD The Liver Meeting® 2019 in Boston, MA, November 8-12, 2019.

 

Title: “EC-18, a novel immune resolution accelerator, improves NASH and liver fibrosis”